The anti-emetic potential of the 5-hydroxytryptamine3 receptor antagonist BRL 43694. (Record no. 2857174)

MARC details
000 -LEADER
fixed length control field 01301 a2200397 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250512022516.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 198903s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0007-0920
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1038/bjc.1988.277
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Bermudez, J
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 19890316
245 00 - TITLE STATEMENT
Title The anti-emetic potential of the 5-hydroxytryptamine3 receptor antagonist BRL 43694.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. British journal of cancer
Date of publication, distribution, etc. Nov 1988
300 ## - PHYSICAL DESCRIPTION
Extent 644-50 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Animals
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Apomorphine
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cisplatin
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cyclophosphamide
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Dogs
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Doxorubicin
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Ferrets
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Granisetron
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Indazoles
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pyrazoles
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Triazines
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Vomiting
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Whole-Body Irradiation
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Boyle, E A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Miner, W D
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Sanger, G J
773 0# - HOST ITEM ENTRY
Title British journal of cancer
Related parts vol. 58
-- no. 5
-- p. 644-50
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1038/bjc.1988.277">https://doi.org/10.1038/bjc.1988.277</a>
Public note Available from publisher's website

No items available.